RAFFA WEALTH MANAGEMENT, LLC’s Edwards Lifesciences EW Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.3K	Buy	136 +11	+9%	+$921	﹤0.01%	383
2026 Q1	$10K	Buy	125 +4	+3%	+$330	﹤0.01%	392
2025 Q4	$10.3K	Buy	121 +13	+12%	+$1.07K	﹤0.01%	369
2025 Q3	$8.4K	Sell	108 -21	-16%	-$1.64K	﹤0.01%	394
2025 Q2	$10.1K	Hold	129	–	–	﹤0.01%	373
2025 Q1	$9.35K	Hold	129	–	–	﹤0.01%	327
2024 Q4	$9.55K	Hold	129	–	–	﹤0.01%	336
2024 Q3	$8.51K	Sell	129 -80	-38%	-$5.81K	﹤0.01%	332
2024 Q2	$19.3K	Buy	209 +80	+62%	+$7.08K	0.01%	329
2024 Q1	$12.3K	Hold	129	–	–	﹤0.01%	394
2023 Q4	$9.84K	Sell	129 -165	-56%	-$11.5K	﹤0.01%	300
2023 Q3	$20.4K	Hold	294	–	–	0.01%	197
2023 Q2	$27.7K	Hold	294	–	–	0.01%	169
2023 Q1	$24.3K	Hold	294	–	–	0.01%	198
2022 Q4	$21.9K	Sell	294 -8	-3%	-$617	0.01%	194
2022 Q3	$25K	Hold	302	–	–	0.01%	183
2022 Q2	$28.7K	Hold	302	–	–	0.01%	177
2022 Q1	$35.6K	Sell	302 -9	-3%	-$1.01K	0.01%	169
2021 Q4	$40.3K	Buy	311 +43	+16%	+$5.02K	0.01%	169
2021 Q3	$30.3K	Hold	268	–	–	0.01%	164
2021 Q2	$27.8K	Buy	268 +165	+160%	+$15.6K	0.01%	174
2021 Q1	$8.62K	Buy	103 +10	+11%	+$845	﹤0.01%	297
2020 Q4	$8.48K	Hold	93	–	–	﹤0.01%	272
2020 Q3	$7.42K	Buy	93 +9	+11%	+$702	﹤0.01%	275
2020 Q2	$5.8K	Buy	84 +21	+33%	+$1.49K	﹤0.01%	291
2020 Q1	$3.96K	Buy	63 +27	+75%	+$1.95K	﹤0.01%	312
2019 Q4	$2.8K	Hold	36	–	–	﹤0.01%	335
2019 Q3	$2.64K	Buy	+36	New	+$2.53K	﹤0.01%	343
2019 Q2	–	Sell	-36	Closed	-$2.3K	–	950
2019 Q1	$2.3K	Sell	36 -4,752	-99%	-$271K	﹤0.01%	335
2018 Q4	$244K	Hold	4,788	–	–	0.09%	58
2018 Q3	$278K	Hold	4,788	–	–	0.1%	73
2018 Q2	$232K	Hold	4,788	–	–	0.09%	63
2018 Q1	$223K	Buy	4,788 +36	+0.8%	+$1.56K	0.08%	72
2017 Q4	$179K	Hold	4,752	–	–	0.07%	85
2017 Q3	$173K	Hold	4,752	–	–	0.07%	86
2017 Q2	$187K	Hold	4,752	–	–	0.08%	80
2017 Q1	$149K	Sell	4,752 -300	-6%	-$9.39K	0.07%	62
2016 Q4	$158K	Hold	5,052	–	–	0.08%	59
2016 Q3	$203K	Hold	5,052	–	–	0.11%	53
2016 Q2	$168K	Hold	5,052	–	–	0.09%	56
2016 Q1	$149K	Hold	5,052	–	–	0.09%	60
2015 Q4	$133K	Hold	5,052	–	–	0.08%	54
2015 Q3	$120K	Hold	5,052	–	–	0.07%	63
2015 Q2	$120K	Hold	5,052	–	–	0.07%	64
2015 Q1	$120K	Hold	5,052	–	–	0.07%	60
2014 Q4	$107K	Hold	5,052	–	–	0.06%	61
2014 Q3	$86K	Hold	5,052	–	–	0.06%	64
2014 Q2	$72.3K	Hold	5,052	–	–	0.06%	64
2014 Q1	$62.5K	Hold	5,052	–	–	0.05%	67
2013 Q4	$107K	Buy	+5,052	New	+$56.9K	0.06%	61

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's EW Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC increased its Edwards Lifesciences (EW) stake by 8.8% in Q2 2026, buying an estimated $921 and bringing the position to 136 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #383.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in EW in Q4 2013 and has held it in 50 quarters since. The position peaked at $278K in Q3 2018. 414 funds tracked by Wall St. Rank hold EW as of Q2 2026.

RAFFA WEALTH MANAGEMENT, LLC held 136 shares of Edwards Lifesciences worth $12.3K as of Q2 2026.
RAFFA WEALTH MANAGEMENT, LLC bought 11 Edwards Lifesciences shares in Q2 2026, an estimated $921.
Edwards Lifesciences made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #383 holding.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in Edwards Lifesciences in Q4 2013 and has held it in 50 quarters since.
RAFFA WEALTH MANAGEMENT, LLC's Edwards Lifesciences position peaked at $278K in Q3 2018.
414 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.